- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03200431
Evaluation of the Influence of Output on Skin Wearing a New Adhesive
January 31, 2018 updated by: Coloplast A/S
Evaluation of the Influence of Output in Skin Covered by Newly Developed Adhesives
The purpose is to investigate the impact real output has on the peristomal skin covered by a newly developed adhesive.
Study Overview
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Humlebæk, Denmark, 3050
- Coloplast A/S
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Have had a stoma for more than one year
- Have intact skin on the area used in the evalua-tion
- Has a stoma with a diameter up to (≤) 35 mm
- Have a peristomal area accessible for application of patches/adhesive strips (assessed by investigating scientist)
Exclusion Criteria:
- Currently receiving or have within the past 2 month received radio- and/or chemotherapy
- Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
- Are pregnant or breastfeeding
- Having dermatological problems in the peristomal- or abdominal area (assessed by investigating scientist)
- Actively participating in other interventional clinical investigations or have previously participated in this investigation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test of a new adhesive strip
This is a sub-study testing the effect of real output applied under two adhesive strips on the skin after 24 hours.
The adhesive strip is not yet part of a marketed ostomy device.
|
This is a newly developed strip.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Trans epidermal water loss
Time Frame: 24 hours
|
The trans epidermal water loss is measured on the peristomal skin using a probe.
The Tran epidermal water loss is a measure for the skins barrier function.
There is always a loss of water from the skin due to natural evaporation.
However, when the skin barrier is damaged the evaporation of water increases leading to a higher trans epidermal water loss.
Thus, trans epidermal water loss is used to assess the damage to the skin.
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 26, 2017
Primary Completion (Actual)
December 11, 2017
Study Completion (Actual)
December 11, 2017
Study Registration Dates
First Submitted
June 26, 2017
First Submitted That Met QC Criteria
June 26, 2017
First Posted (Actual)
June 27, 2017
Study Record Updates
Last Update Posted (Actual)
February 1, 2018
Last Update Submitted That Met QC Criteria
January 31, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- CP265_16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ileostomy - Stoma
-
Chang Gung Memorial HospitalConvaTect, TaiwanUnknownStoma Ileostomy | Stoma ColostomyTaiwan
-
Coloplast A/SCompleted
-
11 Heath and Technologies LimitedThe Cleveland ClinicUnknownIleostomy; Complications | Ileostomy - StomaUnited States
-
Massachusetts General HospitalRecruitingSurgery | Ileostomy - Stoma | Colostomy StomaUnited States
-
BBraun Medical SASRecruitingEnterostomy | Stoma Ileostomy | Stoma ColostomySpain
-
Hospital de BasurtoAlberto Loizate Totoricaguena; Pedro García AlonsoUnknownIleostomy; Complications | Ileostomy - Stoma | Stoma Ileostomy | Ileus ParalyticSpain
-
Coloplast A/SCompletedIleostomy - Stoma | Colostomy StomaDenmark, Sweden
-
University of Southern CaliforniaUnknownIleostomy - Stoma | Colostomy StomaUnited States
-
Coloplast A/SCompletedIleostomy - Stoma | Colostomy - StomaDenmark
-
Coloplast A/SCompletedColostomy Stoma | Ileostomy StomaDenmark
Clinical Trials on New adhesive strip
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted
-
Coloplast A/SCompletedIleostomy - StomaDenmark
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted
-
Coloplast A/SCompleted